Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model Saudi Arabias Vision 2030 Spending Spree Faces Fiscal Reality Check Malaysian Startup Eyes Commercialization of LabGrown Unagi MultiJob Workforce Expands as Cost of Living Pressures Mount AI Job Applications Create a Doom Loop for Recruiters and Candidates Roundhill Memory ETF DRAM Soars Past 60 After Record 65 Billion Launch Highlighting AI Memory Demand BTC Development Corp Unit BDCIU Q1 2026 Earnings Positive EPS Reported Amid Limited Disclosures NUTX Q1 2026 Earnings EPS Surges Past Estimates by 31 as Profitability Improves PCTTU Q1 2026 Earnings SmallerthanExpected Loss Amid PreRevenue Operations ECG Q1 2026 Earnings EPS Surges Past Estimates with 41 Surprise Jupiter Neurosciences JUNS Q4 2025 Earnings EPS Beat Masks ZeroRevenue Reality Shares Slide 12 ABBV Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips PostRelease Cohen Steers REIT and Preferred and Income Fund RNP Holds Steady Near Key Support Level Analog Devices ADI Climbs 335 as Technical Support Holds Eyes Resistance Adagene Inc ADAG Presses Lower Support Test in Sight After 188 Decline Akanda Corp AKAN Plunges 12 Key Levels to Watch Amid Cannabis Sector Volatility Highview Merger Corp HVMC Holds Steady Near Trust Value Amid Merger Anticipation The Mandalorian and Grogu Box Office Projection Lowest Opening in Disneys Star Wars Era Fennec Pharmaceuticals Q1 2026 Earnings EPS Surprise Beats Estimates Amidst PreRevenue Stage Medicus Pharma Ltd MDCX Edges Higher Testing Key Resistance at 032 Wordle 1798 Hints Continue to Draw Audience Interest Implications for Digital Puzzle Engagement PRGO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction OpenAI Reportedly Plans Confidential IPO Filing by May 22 Potential Valuation Up to 1 Trillion CMCO Q1 2026 Earnings EPS Beats Estimates Shares Rally on Operational Momentum MRDN Q1 2026 Earnings Massive EPS Beat Overshadowed by Steep Stock Decline Michael Burry Initiates New Position in PayPal Holdings Inc What It Could Mean for Investors AC Immune Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues